Background: Straight-and branched-chain (BCFA) short-chain fatty acids (SCFAs) are produced by colonic microbiota and have both beneficial and deleterious effects in humans with chronic kidney disease (CKD). Fecal SCFAs in cats with CKD have not been described.
| INTRODUCTION
The gut microbiome and its microbial metabolites have been implicated in the pathogenesis of chronic kidney disease (CKD). In humans with CKD, the number of beneficial colonic bacteria that produce short-chain fatty acids (SCFAs) is decreased with a concurrent increase in bacteria that produce the major uremic toxins indoxyl sulfate (IS), p-cresol sulfate (pCS), and trimethylamine-N-oxide. [1] [2] [3] Although there is limited information regarding the microbiome and its link to kidney disease in veterinary medicine, cats with CKD have fecal dysbiosis characterized by decreased fecal microbial diversity and richness based on 16S ribosomal rRNA gene sequencing. 4 Additionally, IS is increased in cats with CKD and is associated with disease progression, 5, 6 and in some CKD cats, serum pCS concentrations are increased compared to healthy geriatric controls. 4 However, to date, fecal SCFA concentrations have not been characterized in cats with CKD.
The SCFAs produced by the colonic microbiota consist of the straight-chain SCFAs acetic acid, propionic acid, butyric acid, valeric acid, and the branched-chain fatty acids (BCFA) isovaleric acid and isobutyric acid. The straight-chain SCFAs are the most abundant SCFAs in the human intestinal tract, representing 90%-95% of the SCFA present in the colon. 7 Straight-chain SCFAs are major end-products of saccharolytic fermentation of complex polysaccharides (including non-digestible dietary fiber) and epithelialderived mucus, and are essential nutrients vital for both intestinal and host health. 8 They have several beneficial local and systemic effects including promotion of colonic motility, facilitation of lipid and glucose metabolism, blood pressure regulation, and antiinflammatory properties. [9] [10] [11] [12] [13] [14] In contrast, BCFAs represent only a small portion (5%) of total SCFA production and are produced when protein passes through the small intestine unabsorbed and proteinderived branched chain amino acids are fermented by microbiota in the colon. 8, 15, 16 Branched-chain SCFAs and other products of protein fermentation in the colon are considered deleterious to the gut and may promote inflammation as well as have negative effects on motility in a rodent model. [15] [16] [17] Thus, because of the potential implications of SCFA for gut health, our primary aim was to characterize fecal SCFA concentrations in healthy geriatric cats and cats with CKD. A secondary aim was to evaluate the correlation between the fecal SCFA concentrations and serum concentrations of IS and pCS. We hypothesized that cats with CKD would have an altered SCFA profile when compared to healthy control cats, and fecal BCFAs would correlate positively to serum concentrations of IS and pCS. 4 A client questionnaire was provided to the owner and the following information was obtained: diet (brand name and amount offered of wet or dry food or both), current medications or supplements, medications or supplements administered in previous 3 months, appetite and fecal score (Nestle Purina) at the time of enrollment, clinical signs of constipation, and frequency of vomiting. A table with descriptions of   MCS, appetite, fecal, and vomiting scores is provided in Table S1 . The project was approved by the Clinical Review Board (#2016-080) at Colorado State University, and all owners gave written informed consent before participation.
| Fecal fatty acid analysis
At least 1 g of voided feces was collected by the owner within 12 hours of defecation and placed on ice until frozen within 24 hours of collection.
The samples were stored at −80 C until analysis of fecal fatty acid concentrations. Fecal concentrations of straight-chain SCFAs (i.e., acetic acid, propionic acid, butyric acid, valeric acid) and BCFAs (i.e., isobutyric acid, isovaleric acid) were measured using a stable isotope dilution gas chromatography-mass spectrometryassay as previously described 19 with some modifications. Briefly, the fecal samples were weighed, 
| Assays for serum IS and p-CS concentrations
Blood was collected in sterile non-heparinized tubes and centrifuged at 5000 rpm for 5 minutes. Serum was harvested and samples were frozen and stored at −80 C until analysis by Colorado State University. Total IS and pCS serum concentrations were determined by liquid chromatography tandem mass spectrometry as previously described. 4 The accuracy +/− coefficient of variation of quality assurance/quality control samples among the batches analyzed for this study was 93.7% ± 4.8% for IS and 92.5% ± 4.0% for pCS. 
| Statistical analysis

| Cats
Fecal straight-chain SCFA and BCFA concentrations were measured in 28 cats with CKD (16 cats had IRIS CKD stage 2, 10 cats had IRIS CKD stage 3, 2 cats had IRIS CKD stage 4) and 11 healthy geriatric control cats. Serum IS and pCS concentrations were available in a subset of healthy control cats (n = 10) and CKD cats (n = 26) from a previous analysis on the study population. 4 Descriptions of age, BCS, MCS, clinical scores, and diagnostic laboratory findings from cats in each group (healthy geriatric cats, IRIS CKD stage 2 cats, IRIS CKD stage 3 and 4 cats) are summarized in Table 1 . Twenty-one of 28 (75%) cats with CKD had a urinary ultrasound examination with 18 of 28 cats having changes consistent with chronic renal degenerative disease, 2 of 29 cats with apparently normal renal architecture, and 1 of 29 cats with chronic unilateral obstructive ureteroliths and concurrent renal degenerative disease.
No sonographic evidence of neoplasia or pyelonephritis was identified in the CKD cats. Abdominal imaging was not performed on healthy geriatric cats. Healthy geriatric cats were significantly younger compared to the IRIS CKD stage 2 cats (P = .006). No significant difference was found in the age of IRIS CKD stage 3 and 4 cats compared to healthy geriatric cats and IRIS CKD stage 2 cats. Serum total T4 concentration at time of enrollment excluded hyperthyroidism. Two CKD cats had serum total T4 concentration <1.0 which was suspected to be associated with non-thyroidal illness. All healthy geriatric controls and most CKD cats (22/28) were negative for proteinuria on urine dipstick testing. Of the 6 of 28 CKD cats that had ≥1+ protein on urine dipstick testing, only 3 had borderline proteinuria (UPC, 0.22, 0.23, 0.24), and the remaining cats were non-proteinuric (UPC < 0.2).
When clinical scores (BCS 1-9, MCS 0-3, fecal score 1-7, vomiting score 0-3, appetite score 0-4) were compared between healthy geriatric cats and CKD cats, BCS was not significantly different between healthy control cats and CKD cats. Despite a similar BCS, MCS and thus severity of muscle atrophy were significantly more prominent in CKD cats (median score, 1; range, 0-3) compared to healthy geriatric cats (median score, 0; range, 0-1; P = .0002). When MCS was compared between stages of CKD, IRIS stage 2 (P = .048) and IRIS stage 3 and 4 (P = .0009) CKD cats had significantly more muscle atrophy when compared to healthy geriatric cats, but no difference was found between IRIS CKD stage 2 and stage 3 and 4 cats ( Figure 1 ). Based on the owner questionnaire, cats with CKD (median score, 2; range, 0-3) vomited more frequently compared to the healthy control cats (median score, 0; range, 0-2; P = .004). Cats with CKD had poorer appetite (median score, 1; range, 0-3) compared to healthy control cats (median score, 0; range, 0-1; P = .001). Fecal score was not significantly different between healthy control cats and CKD cats. range, 2.9-7.4; P = .02; Figure 2 ). When compared between the stages of CKD, IRIS CKD stage 3 and 4 cats had significantly higher (P = .03) fecal concentrations of isovaleric acid compared to healthy geriatric cats, but no significant difference was found between IRIS CKD stage 2 cats and IRIS CKD stage 3 and 4 cats, or between IRIS CKD stage 2 cats and healthy geriatric cats ( Table 2) .
When total fecal straight-chain SCFA, total fecal BCFA, and individual fecal fatty acid concentrations (i.e. acetic acid, propionic acid, butyric acid, isovaleric acid, isobutyric acid, valeric acid) were compared to clinical scores (BCS, MCS, vomiting score, and appetite score categories) for all enrolled cats, no significant difference was found for BCS, vomiting score, or appetite score categories. For MCS, fecal total BCFA concentrations (P = .01; Figure 3 ), isovaleric acid concentrations (P = .01), and isobutyric acid concentrations (P = .03) were significantly higher in cats with muscle atrophy (MCS 1-3) compared to cats with a normal muscle mass (MCS 0; Table 3 ). Serum IS concentrations were significantly higher in cats with muscle atrophy compared to cats without muscle atrophy (P = .01). No significant difference was found in serum pCS concentrations between cats with and without muscle atrophy.
No significant differences in total or individual fecal SCFA concentrations were found when all CKD cats consuming exclusively a prescription renal diet were compared to those not exclusively consuming a renal diet. No significant differences in fecal SCFA concentrations were found between cats of the same CKD stage exclusively consuming a renal diet 
F I G U R E 2
Fecal isovaleric acid concentrations in healthy geriatric cats and cats with IRIS stage 2-4 CKD. Significantly higher isovaleric acid concentrations were seen in cats with CKD in comparison to healthy geriatric cats (P = .02). Significance remained when data were analyzed without outlier (P = .02). Dot plot illustrates the median values. CKD, chronic kidney disease; IRIS, International Renal Interest Society in comparison to those not exclusively consuming a renal diet, However, the highest concentrations of isovaleric acid in IRIS CKD stage 3 and 4 cats were observed in those cats not consuming a renal diet (n = 6; median, 14.7 μmol/g; range, 3.2-65.1) versus IRIS CKD stage 3 and 4 cats that were consuming a renal diet (n = 5; median, 9.4 μmol/g; range, 2.5-10.1). toxins IS and pCS are produced when amino acids escape absorption in the small intestine and are metabolized by the colonic microbiota. 15 Because cats with CKD have higher serum IS and pCS concentrations, 4,5 these findings taken together suggest that cats with CKD may have protein malassimilation in the upper small intestinal tract. Similar findings are seen in both rat models and in humans with end-stage renal disease (ESRD) where increased abundance of proteolytic bacteria and increased amounts of undigested amino acids in the colon have been described. 20, 21 Protein malassimilation also is documented in humans with CKD. 22 In 1 study, the percentage of dietary protein-derived leucine that appeared in plasma after consumption was significantly decreased (41% ± 5%) compared to healthy controls (61% ± 4%). 23 This finding is of particular interest because leucine is an amino acid that results in formation of BCFA in the colon.
Spearman correlation coefficients and P-values
Cats with muscle atrophy (MCS 1-3) had significantly higher fecal isovaleric acid, isobutyric acid, and total BCFA concentrations as compared to cats with normal muscle mass (MCS 0). Previous literature suggests that weight loss and muscle wasting in human ESRD patients is caused, at least in part, by impaired small intestinal protein digestion and absorption as well as by alterations in protein metabolism and inadequate protein intake. 24, 25 This scenario may be further complicated by age-related changes in cats, with decreased protein digestibility described as an aspect of impaired digestive function in geriatric cats. 26 In our study, 1 IRIS CKD stage 3 cat was an outlier compared to the other enrolled cats and had an extremely high fecal isovaleric acid concentration (Figure 2 ). When investigated, it was discovered that this patient was being fed a partially raw, high protein diet moting contraction of smooth muscle in the colon in ex vivo studies evaluated in colonic tissue from dogs, 28 cats, 29 and guinea pigs, 30 BCFAs and other products of protein fermentation in the colon are considered deleterious to the gut. For example, isovaleric acid has been shown to cause colonic smooth muscle relaxation in an ex vivo rodent model. 17 In addition, decreased gastrointestinal motility has been linked directly to uremia by causing dysbiosis and colonic inflammation secondary to increased uremic toxin exposure in rodent models. [31] [32] [33] In an ex vivo rodent model, incubation of colons with the gut-derived uremic toxins IS and pCS, but not urea, was shown to decrease force of contraction by 66% and 55%, respectively. 33 This finding supports the idea that uremia directly causes impaired colonic motility, although other factors such as dehydration and hypokalemia also may be factors. Constipation is a common problem in humans on hemodialysis and has been shown to negatively impact health-related quality of life. 34, 35 Although the prevalence of constipation in cats with CKD is unknown, CKD in cats is associated with an increased risk of constipation. 36 It is possible that higher fecal isovaleric acid and serum IS concentrations in CKD cats might contribute to constipation.
In our study population, only 2 of 30 CKD cats had a fecal score of 1 (small hard feces) that may be associated with constipation, and no owners reported concern for overt signs of constipation in their CKD cats. However, subtle signs of constipation are difficult to detect for cat owners, and normal feces does not exclude the possibility of decreased frequency of defecation. Additional studies assessing the relationships among fecal isovaleric acid, defecation frequency, and stool quality are warranted.
Cats with CKD did not have significantly different fecal straightchain SCFA concentrations as compared to healthy geriatric cats.
Factors that affect straight-chain SCFA concentrations include the amount and type of fermentable carbohydrate consumption, composition and diversity of the intestinal microbiota, colonic transit time, and interactions between microbes and the host. [37] [38] [39] In humans with CKD and ESRD, it is commonly recommended to decrease the dietary intake of fruits and vegetables to limit potassium intake and prevent hyperkalemia. 40 This decrease in dietary fiber leads to a decrease in bacterial groups known to produce straight-chain SCFAs in the colon, in particular butyric acid. 1, 41 Dietary fiber restriction to prevent hyperkalemia is not recommended in cats with CKD because hypokalemia is a more common sequela of the disease. Therefore, microbial SCFA production may not be affected in cats to the same extent as in humans with CKD. Although cats are obligate carnivores, and comparison to humans may not be appropriate, it has been documented that dietary protein and fiber intake and nutrient sources affect both the microbiome composition of cats and microbial metabolite production in healthy cats, similar to what is observed in humans. [42] [43] [44] [45] Specifically, the fiber source has been shown to affect fecal SCFA concentrations in healthy cats. 42 A previous study evaluated the effect that 3 fiber sources with differences in fermentability, solubility, and prebiotic potential had on fecal microbial metabolites in healthy cats. Fecal acetate and propionate concentrations increased in cats that received a highly soluble, fermentable fiber (pectin), whereas fecal butyrate and BCFAs increased after supplementation with rapidly fermented, prebiotic fiber (fructooligosaccharide), and pectin. 42 In our study, the diets of the enrolled cats were variable, and unfortunately the fiber source and intake for the cats could not be accurately determined. In addition, the specific microbiota responsible for SCFA production has yet to be determined in veterinary medicine. Although fecal bacterial composition determined by 16S rRNA gene sequencing previously was published in the same group of cats and the study confirmed dysbiosis in cats with CKD, no specific bacterial taxa were associated with the CKD cats compared to healthy geriatric cats. 4 To further define the link between gut microbial composition and SCFA production in cats, shotgun metagenomic analysis on fecal samples in conjunction with targeted analysis of fecal SCFAs in cats on a welldefined diet is needed to determine the bacterial groups responsible for fecal acid production in the colon of cats.
A few observations are important to note when evaluating differ- Our study had several limitations. As previously mentioned, accurate determination of dietary protein and fiber intake was not possible because of the common practice of feeding a mixture or rotation of diets. Thus, analysis of a relationship between dietary protein and fiber source and fecal fatty acid concentrations was not possible.
Although observations in people largely rely on the measurement of fecal SCFA concentrations, it is unclear whether fecal SCFA concentrations are a reliable proxy for luminal SCFA production. 46 With regard to the cat populations, the control group was age-group-matched (≥ 8 years)
rather than age-matched to the CKD group. Because of the high prevalence of CKD in geriatric cats and the presence of concurrent disease (e.g., hyperthyroidism, chronic enteropathy), an age-matched healthy control population could not be identified in the referral hospital population of cats. Additionally, although cats receiving medications documented to affect the microbiome in veterinary species were excluded from the study, several enrolled cats with CKD were receiving medications that might have affected the microbiome to an unknown extent. Because CKD patients typically are receiving multiple medications to manage their disease, it was not feasible to only enroll cats not receiving medication.
Because of the exclusion criteria, only 2 IRIS stage 4 CKD cats were enrolled in our study; therefore, IRIS stage 3 and 4 CKD cats were combined into a single group for statistical analysis. Moreover, 2 cats with CKD maintained normal USG >1.035 and were diagnosed in accordance with IRIS recommendations 18 based on persistently increased serum creatinine concentration >1.6 mg/dL over a 3-month period and increased serum SDMA concentration. An additional limitation was that muscle mass score was based on physical examination, which previously has been shown to be somewhat imprecise. 47 Lastly, a few geriatric cats in the healthy control group had laboratory results on the serum biochemistry panel that were outside the reference range (Table 1) . Although the abnormal results were minimal, and not considered clinically relevant, we cannot exclude the possibility that the healthy control cat had subclinical disease that could have explained these abnormalities.
In conclusion, CKD in cats is associated with increased fecal isovaleric acid, particularly in IRIS CKD stage 3 and 4 cats. Fecal BCFA concentrations were positively correlated with serum pCS concentrations and severity of azotemia. Cats with muscle atrophy had higher fecal BCFA concentrations compared to cats without muscle atrophy. These findings support malassimilation of protein in cats with CKD. Future studies are needed to fully elucidate links among the gut microbiome, protein malassimilation, microbial fatty acid production, and clinical consequences in cats with CKD.
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